If you work in Medicare long enough, you learn not to get comfortable.
The 2027 Medicare Advantage payment cycle gave us a pretty good example. In January, CMS's Advance Notice projected a 0.09% average year-over-year increase in MA payments. By April, the final Rate Announcement projected a 2.48% increase, or more than $13 billion.
That's a substantial change in less than three months, and payment rates are only one moving piece. Across Medicare, organizations are dealing with tighter economics, greater scrutiny and increasing pressure to prove value.
Agencies are looking beyond an MA-only business. Carriers and distribution organizations are working to protect productive relationships as the market changes. Technology companies have to prove they're solving a real business problem, not adding another tool to the stack.
Across the market, the pressure is familiar: control costs, protect revenue, retain valuable relationships and get more from the people and resources already in place.
I've spent enough time in this industry to know we aren't going to predict every turn correctly.
So, I think there's a better question for agencies, FMOs, IMOs, carriers and Medicare technology companies:
What still works when Medicare keeps changing? Quite a lot, actually.
Those industry pressures aren't all marketing problems. But they absolutely change the environment marketing has to work in.
Know Exactly Who You're Trying to Reach
"Medicare audience" isn't specific enough.
An FMO recruiting productive agencies has a different buyer than a carrier trying to increase broker awareness. An agency building consumer demand has a different job than a technology company selling an enrollment platform.
That sounds obvious. Yet I still see marketing trying to make one message work for producers, agency owners, carrier executives and beneficiaries.
Start narrower.
- Who specifically needs to act?
- What are they trying to accomplish?
- What would make them pay attention right now?
The differences are getting more consequential. An agency owner looking beyond an MA-only business may be thinking about ACA, ancillary products or other ways to serve clients. An FMO may be thinking about recruiting productive agents while keeping the ones it has already engaged. A carrier distribution team may need to keep changing products, benefits and market availability clear across a large producer network. A technology buyer may be under pressure to consolidate vendors, improve integration and prove ROI.
Those people may all work in Medicare distribution. They aren't having the same conversation.
The more complicated the market gets, the less room there is for vague marketing.
Give People a Clear Reason to Choose You
Products change. Commissions change. Technology gets copied. Competitors add services.
And some of the traditional reasons organizations have competed are getting harder to own. If multiple organizations can offer access to similar products, comparable technology or familiar support services, the question becomes what makes the relationship itself valuable.
That is especially important when agencies are diversifying; carriers are competing for productive distribution and technology buyers are questioning whether another point solution deserves a place in the stack.
Your value proposition has to survive those changes.
For an FMO or IMO, that may mean being known for the support that makes producers more effective. For an agency, it could mean helping clients across a broader set of coverage needs. For a Medicare technology company, "innovative platform" isn't much of a position anymore. Buyers need to understand where the technology fits, what problem it solves and why changing their current workflow is worth it.
If your sales team needs five minutes to explain why you're different, marketing has work to do.
Show Up Before Somebody Needs You
Medicare has obvious moments of urgency. That doesn't mean your marketing calendar should begin and end with them.
An agency doesn't decide where to place business because of one email. A producer doesn't build trust with an FMO after seeing one ad. A carrier relationship isn't created by a product announcement. A technology buyer may encounter your company through search, an AI answer, LinkedIn, an industry event, a peer recommendation and a sales conversation before anybody schedules a demo.
There’s a useful progression here: awareness → recognition → active recall → top of mind. One interaction may create awareness. Repeated, relevant exposure creates familiarity. Eventually, the goal is active recall: when an agent, broker or buyer has a need, your company is one of the names that comes to mind.
That repeated exposure matters.
It may matter even more when the market is unsettled. When a product changes, a carrier exits a market, an agency explores a new revenue stream or a company suddenly needs different technology, the consideration set isn't necessarily built that day. The organizations already known and trusted have a head start.
The companies that stay useful and visible throughout the year don't have to introduce themselves from scratch every time an opportunity appears.
Be Useful Enough to Remember
AI has made producing more content remarkably easy. It hasn't made anyone more interested in reading generic content.
That's an important distinction.
An analysis of more than one million AI responses found that AI engines are looking for “net new information.” In plain English, repeating what already exists gives both people and AI very little reason to choose your version.
A recap of a CMS announcement may earn a click. Explaining what the change means for a specific Medicare business and what its leaders should consider next gives someone a reason to remember who wrote it.
Look at what Medicare businesses are sorting through right now: risk adjustment and RADV, Star Ratings, prior authorization, Part D changes, AI and compliance, changing agent and broker requirements, retention and product diversification.
The opportunity isn't to publish a post every time one of those subjects appears in the news. It's to know which changes affect your audience and explain the implication better than someone who merely read the same announcement.
And “new” doesn't have to mean commissioning a national research study. It can be the questions agents keep asking, patterns your sales team is seeing, conversations with distribution partners, customer data, implementation experience or an informed opinion about where the market is heading.
The subject-matter expertise has to come first.
Answer the actual question. Add context. Provide proof. Explain the business implication. Have a point of view earned by knowing the industry.
More content isn't much of an advantage when everybody can make more content. Knowing something worth publishing is.
Give Sales a Story They Can Easily Carry
Marketing shouldn't make your sales team translate the company story for you.
If producers, account executives, business development teams or carrier reps can't quickly explain who you help, the problem you solve and why someone should care, another campaign won't fix the underlying issue.
Good marketing makes that story easier to carry from a website to a conference conversation to a follow-up email.
And in a relationship-driven business like Medicare distribution, that's a big job.
It's an even bigger job when the story itself is changing. Agents have more to weigh than whether a product is available. They need a reason to trust the organization behind it and understand where it fits for their business and clients. Agencies may be introducing products their producers haven't traditionally sold. Carrier teams may be communicating benefit or market changes. Technology companies may be asking organizations to change established workflows.
In each case, sales enablement has to help someone explain why the change is worth making.
Measure Whether Any of This Is Moving the Business
Clicks and impressions have their place. They aren't the business result. Look further downstream.
Are the right agencies engaging? Are producers responding? Is branded search increasing? Are target accounts returning to the website? Is sales using the content? Are prospects arriving better informed? Which campaigns contribute to qualified conversations?
That's especially important when budgets and margins are under pressure. “Marketing generated 2,000 clicks” isn't particularly useful if leadership is trying to decide where to invest limited dollars, which markets deserve attention or whether an agency recruitment campaign is producing agents who actually write business.
The closer marketing measurement gets to the commercial question leadership is trying to answer, the more useful it becomes.
Not every useful marketing touch will produce a neat one-to-one attribution trail. That doesn't excuse us from measuring what we can.
It means connecting marketing activity to the way the business actually sells.
Build for The Next Change, Not The Last One
Medicare will keep changing. Payment economics will shift. Rules will change. Products will enter and leave markets. Technology will keep advancing. The economics of distribution will keep evolving.
The marketing question is whether you're building something durable while you do it.
Know your audience. Make the reason to choose you unmistakable. Stay present between the obvious selling moments. Turn your expertise into something useful. Give sales a story worth carrying. Then pay attention to whether the market is responding.
You can't build a Medicare business around perfectly predicting what changes next. You can build one that's much better prepared when it does.
That's the part worth getting right.
Is your marketing built for where the Medicare market is going next?
Ocozzio helps Medicare agencies, FMOs, IMOs, carriers and technology companies turn business challenges into smarter marketing strategy and execution.
[Let’s Talk]
Medicare Marketing FAQs
How should Medicare organizations market when the industry keeps changing?
Medicare organizations should market around durable business fundamentals rather than a single product, regulation or selling season. Know which audience you need to influence, make your differentiation easy to understand, communicate throughout the year and give sales or distribution partners useful reasons to keep your organization top of mind. When Medicare changes, the message may need to change. The entire marketing foundation shouldn’t have to.
Should Medicare marketing only focus on AEP?
No, Medicare marketing should continue throughout the year, not only during AEP. Producer recruiting, agency engagement, carrier relationships, partner education, brand building and technology evaluation can all require repeated exposure well before enrollment begins. AEP may be the deadline. It shouldn’t be the introduction.
How can FMOs, IMOs and carriers market more effectively to Medicare agents and agencies?
FMOs, IMOs and carriers can market more effectively by clearly showing the right agents and agencies why the relationship is valuable to their business. Product information and compensation matter, but so do education, sales support, technology and responsiveness. Marketing should make that value easy to understand before a recruiter or sales representative has to explain it.
How should Medicare technology companies market to agencies, carriers and distribution organizations?
Medicare technology companies should lead with the business problem they solve and how their technology fits into the buyer’s existing workflow. Buyers need to understand who will use the platform, what process it improves and what evidence supports its value. As AI and new technology become more common, simply being “innovative” is less useful than showing exactly what gets better for the buyer.